Department of Cardiology, Debakey Cardiovascular Institute, Houston Methodist, Houston, TX, USA.
University of California San Diego, La Jolla, CA, USA.
Vasc Health Risk Manag. 2023 May 12;19:303-316. doi: 10.2147/VHRM.S380270. eCollection 2023.
The long-term implications of COVID-19 have garnered increasing interest in recent months, with Long-COVID impacting over 65 million individuals worldwide. Postural orthostatic tachycardia syndrome (POTS) has emerged as an important component of the Long-COVID umbrella, estimated to affect between 2 and 14% of survivors. POTS remains very challenging to diagnose and manage - this review aims to provide a brief overview of POTS as a whole and goes on to summarize the available literature pertaining to POTS in the setting of COVID-19. We provide a review of available clinical reports, outline proposed pathophysiological mechanisms and end with a brief note on management considerations.
近几个月来，人们对 COVID-19 的长期影响越来越感兴趣，全球有超过 6500 万人受到长期 COVID 的影响。体位性心动过速综合征（POTS）已成为长期 COVID 的一个重要组成部分，据估计，有 2%至 14%的幸存者受到影响。POTS 的诊断和管理仍然极具挑战性——这篇综述旨在全面概述 POTS，并总结 COVID-19 背景下关于 POTS 的现有文献。我们回顾了现有的临床报告，阐述了提出的病理生理机制，并简要介绍了管理注意事项。
